FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885261086> ?p ?o ?g. }

• W2885261086 abstract "Introduction: Peripheral arterial disease (PAD) is a strong predictor of systemic atherosclerosis with substantial morbidity and mortality. Medical management in PAD and coronary artery disease (CAD) has changed in recent eras with the use of high intensity statin and dual antiplatelet therapies. Hypothesis: Test whether mortality and major adverse cardiovascular events (MACE) (death and MI) has decreased over eras among PAD patients undergoning revascularization with percutaneous coronary intervention (PCI). Methods: Longitudinal cohort study of 549 patients who underwent PCI and non-invasive lower arterial study between 1997 and 2008 as identified in the Mayo Clinic PCI registry were stratified into 2 time eras: 1997-2003 (era1), and 2004-2008 (era2). PAD was assessed using the highest resting ABI and stratified according to established categories; < 0.90 (definite PAD); 1.00-1.39 (normal); and ≥ 1.40 defined a non-compressible artery. Kaplan-Meier methods were used to analyze follow-up survival. Results: Stratified by ABI over both time eras, 225 patients had PAD, 94 were non-compressible, and 142 were normal. Overall mortality rates were higher in era2 non-compressible and PAD patients than in non-PAD patients when compared to era1 (58%, 33%, 26%, vs 49% 32%, 19%, p<0.001 for all within-era comparisons) (Figure 1). MACE-free survival were higher in era2 non-compressible and PAD patients than in non-PAD patients when compared to the era1 (64%, 41%, 29% vs 59% 39%, 25%, p≤0.005 for all within-era comparisons). There were significant differences in medical therapy between era2 vs. era1 with higher discharge use of aspirin (98%; 94%), beta-blockers (88%; 66%), any lipid lowering drugs (86%; 76%), ACE inhibitors (67%; 56%), and diuretics (52%; 40%). Conclusions: Over the past two eras, the overall mortality has increased among patients with PAD and non-compressible vessels in era2 vs. era1 despite higher utilization of statin and antiplatelet therapies." @default.
• W2885261086 created "2018-08-22" @default.
• W2885261086 creator A5000110857 @default.
• W2885261086 creator A5067121007 @default.
• W2885261086 creator A5070584585 @default.
• W2885261086 creator A5077077033 @default.
• W2885261086 creator A5080672977 @default.
• W2885261086 date "2017-11-14" @default.
• W2885261086 modified "2023-09-25" @default.
• W2885261086 title "Abstract 21004: Relation Between Optimal Medical Therapy Trends on Outcomes in Patients With Peripheral Arterial Disease and Coronary Artery Disease Undergoing Cardiac Catheterization" @default.
• W2885261086 doi "https://doi.org/10.1161/circ.136.suppl_1.21004" @default.
• W2885261086 hasPublicationYear "2017" @default.
• W2885261086 type Work @default.
• W2885261086 sameAs 2885261086 @default.
• W2885261086 citedByCount "0" @default.
• W2885261086 crossrefType "journal-article" @default.
• W2885261086 hasAuthorship W2885261086A5000110857 @default.
• W2885261086 hasAuthorship W2885261086A5067121007 @default.
• W2885261086 hasAuthorship W2885261086A5070584585 @default.
• W2885261086 hasAuthorship W2885261086A5077077033 @default.
• W2885261086 hasAuthorship W2885261086A5080672977 @default.
• W2885261086 hasConcept C126322002 @default.
• W2885261086 hasConcept C141071460 @default.
• W2885261086 hasConcept C164705383 @default.
• W2885261086 hasConcept C2778213512 @default.
• W2885261086 hasConcept C2779464278 @default.
• W2885261086 hasConcept C2780400711 @default.
• W2885261086 hasConcept C2780739214 @default.
• W2885261086 hasConcept C45393284 @default.
• W2885261086 hasConcept C500558357 @default.
• W2885261086 hasConcept C71924100 @default.
• W2885261086 hasConcept C72563966 @default.
• W2885261086 hasConceptScore W2885261086C126322002 @default.
• W2885261086 hasConceptScore W2885261086C141071460 @default.
• W2885261086 hasConceptScore W2885261086C164705383 @default.
• W2885261086 hasConceptScore W2885261086C2778213512 @default.
• W2885261086 hasConceptScore W2885261086C2779464278 @default.
• W2885261086 hasConceptScore W2885261086C2780400711 @default.
• W2885261086 hasConceptScore W2885261086C2780739214 @default.
• W2885261086 hasConceptScore W2885261086C45393284 @default.
• W2885261086 hasConceptScore W2885261086C500558357 @default.
• W2885261086 hasConceptScore W2885261086C71924100 @default.
• W2885261086 hasConceptScore W2885261086C72563966 @default.
• W2885261086 hasIssue "suppl_1" @default.
• W2885261086 hasLocation W28852610861 @default.
• W2885261086 hasOpenAccess W2885261086 @default.
• W2885261086 hasPrimaryLocation W28852610861 @default.
• W2885261086 hasRelatedWork W2002781300 @default.
• W2885261086 hasRelatedWork W2290116154 @default.
• W2885261086 hasRelatedWork W2366718726 @default.
• W2885261086 hasRelatedWork W2593528227 @default.
• W2885261086 hasRelatedWork W2960274327 @default.
• W2885261086 hasRelatedWork W3080136376 @default.
• W2885261086 hasRelatedWork W3087695759 @default.
• W2885261086 hasRelatedWork W3157744453 @default.
• W2885261086 hasRelatedWork W3206201424 @default.
• W2885261086 hasRelatedWork W4282935957 @default.
• W2885261086 hasVolume "136" @default.
• W2885261086 isParatext "false" @default.
• W2885261086 isRetracted "false" @default.
• W2885261086 magId "2885261086" @default.
• W2885261086 workType "article" @default.